13D Filing: Bain Capital Life Sciences Fund, L.p. and Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

Page 11 of 12

Page 11 of 12 – SEC Filing


CUSIP No. 253031108 13D Page
11

of 12

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true,
complete and correct.

Dated: April 13, 2017

Bain Capital Life Sciences Fund, L.P.
By: Bain Capital Life Sciences Partners, LP, its general partner
By: Bain Capital Life Sciences Investors, LLC, its general partner
By:

/s/ Adam Koppel

Name: Adam Koppel
Title: Managing Director
BCIP Life Sciences Associates, LP
By: Boylston Coinvestors, LLC, its general partner
By:

/s/ Adam Koppel

Name: Adam Koppel
Title: Authorized Signatory

Follow Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

Page 11 of 12